REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Aygpharma S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Aygpharma S A S Profile Updated: March 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Aygpharma S A S is an enterprise based in Colombia. Its main office is in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on April 04, 2006. It currently has a total number of 16 (2026) employees. From the latest financial highlights, Aygpharma S A S reported a net sales revenue increase of 17.44% in 2025. Its total assets grew by 54.2% over the same period. The net profit margin of Aygpharma S A S increased by 0.34% in 2025.

Headquarters
Cra 101 B # 23 D 18
Bogota D.C.; Bogota D.C; Postal Code: 0703

Contact Details: Purchase the Aygpharma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Aygpharma S A S report to view the information.
Financial Auditors:
Purchase the Aygpharma S A S report to view the information.
Incorporation Date:
April 04, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Aygpharma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
17.44%▲
Total Operating Revenue
17.44%▲
Operating Profit
4.04%▲
Net Profit/Loss for the Period
24.41%▲
Total Assets
54.2%▲
Total Equity
36.32%▲
Operating Profit Margin
-1.84%▼
Net Profit Margin
0.34%▲
Return on Equity (ROE)
-1.4%▼
Quick Ratio
1.08%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo